Blockchain Registration Transaction Record

InMed Pharmaceuticals Reports Positive Results from Long-Term INM-901 Study for Alzheimer’s Disease

InMed Pharmaceuticals reports positive results from a long-term study of INM-901, showing potential breakthroughs in Alzheimer’s disease treatment. The study confirms improvements in cognitive function, memory, and locomotor activity, addressing the critical need for effective treatments.

This news matters as it highlights potential breakthroughs in Alzheimer’s disease treatment, with InMed Pharmaceuticals showing promising results in improving cognitive function and memory. The positive findings from the long-term study of INM-901 could lead to the development of effective treatments, addressing a critical need in the medical field.